StockData
Ingevity Corp logo

Ingevity Corp (NGVT) stock

NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30134% above fair value
$53.75−2.21 (-3.95%)

Close on Nov 20, 2026Market cap $1.85BP/E 36.6Yield –

Ingevity free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Ingevity's free cash flow for the twelve months ending Jun 30, 2026 was $154.90M, up 3.1% year over year. For fiscal 2025 it was $273.50M, up 436.3% from the year before. The highest annual figure on record is $273.50M in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$273.50M+436.3%
FY2024Dec 31, 2024$51.00M-46.5%
FY2023Dec 31, 2023$95.30M-44.2%
FY2022Dec 31, 2022$170.90M-9.8%
FY2021Dec 31, 2021$189.50M-29.9%
FY2020Dec 31, 2020$270.30M+68.0%
FY2019Dec 31, 2019$160.90M+1.8%
FY2018Dec 31, 2018$158.10M+29.9%
FY2017Dec 31, 2017$121.70M+70.9%
FY2016Dec 31, 2016$71.20M–
FY2015Dec 31, 2015-$28.70M-178.2%
FY2014Dec 31, 2014$36.70M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$24.10M-136.1%
Q1 FY2026Mar 31, 2026-$12.30M-179.9%
Q4 FY2025Dec 31, 2025$73.50M+85.6%
Q3 FY2025Sep 30, 2025$117.80M+313.3%
Q2 FY2025Jun 30, 2025$66.80M+475.9%
Q1 FY2025Mar 31, 2025$15.40M–
Q4 FY2024Dec 31, 2024$39.60M+132.9%
Q3 FY2024Sep 30, 2024$28.50M-60.3%
Q2 FY2024Jun 30, 2024$11.60M-56.6%
Q1 FY2024Mar 31, 2024-$28.70M–
Q4 FY2023Dec 31, 2023$17.00M-65.5%
Q3 FY2023Sep 30, 2023$71.70M+12.0%
Q2 FY2023Jun 30, 2023$26.70M-56.2%
Q1 FY2023Mar 31, 2023-$20.10M–
Q4 FY2022Dec 31, 2022$49.30M+26.7%
Q3 FY2022Sep 30, 2022$64.00M-14.2%
Q2 FY2022Jun 30, 2022$60.90M+45.3%
Q1 FY2022Mar 31, 2022-$3.30M-109.7%
Q4 FY2021Dec 31, 2021$38.90M-68.2%
Q3 FY2021Sep 30, 2021$74.60M+1.5%
Q2 FY2021Jun 30, 2021$41.90M+23.6%
Q1 FY2021Mar 31, 2021$34.10M-16.2%
Q4 FY2020Dec 31, 2020$122.20M+142.0%
Q3 FY2020Sep 30, 2020$73.50M-23.9%
Q2 FY2020Jun 30, 2020$33.90M-32.1%
Q1 FY2020Mar 31, 2020$40.70M–
Q4 FY2019Dec 31, 2019$50.50M+4.6%
Q3 FY2019Sep 30, 2019$96.60M+39.8%
Q2 FY2019Jun 30, 2019$49.90M+12.6%
Q1 FY2019Mar 31, 2019-$36.10M–
Q4 FY2018Dec 31, 2018$48.30M+98.8%
Q3 FY2018Sep 30, 2018$69.10M+3.9%
Q2 FY2018Jun 30, 2018$44.30M+26.2%
Q1 FY2018Mar 31, 2018-$3.60M–
Q4 FY2017Dec 31, 2017$24.30M-29.4%
Q3 FY2017Sep 30, 2017$66.50M+191.7%
Q2 FY2017Jun 30, 2017$35.10M–
Q1 FY2017Mar 31, 2017-$4.20M–
Q4 FY2016Dec 31, 2016$34.40M–
Q3 FY2016Sep 30, 2016$22.80M–

More Ingevity figures

See a number that looks wrong?